December 08, 2020
As per the latest research report titled ‘Left Atrial Appendage Closure Devices Market Size By Product, By Procedure, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report LLC, worldwide left atrial appendage closure devices market is anticipated to amass record growth through 2026.
Rising pervasiveness of atrial fibrillation leading to higher risk of strokes, in tandem with soaring geriatric population are stimulating the growth of left atrial appendage closure devices market. Further, technological advancements, supportive government initiatives, and strong product pipeline are augmenting the market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2696878/
On the contrary, high cost of left atrial appendage (LAA) closure devices and availability of alternate technologies are restraining the renumeration scale of the market.
As per product terrain, left atrial appendage closure devices market share is divided into epicardial LAA devices, and endocardial LAA devices. The report cites that epicardial LAA devices segment is expected to grow with a CAGR of 26.4% through 2026.
Based on procedure type, the market is classified into surgical, and percutaneous, wherein the former segment is anticipated to expand at 27% CAGR over 2020-2026.
Moving on to end-use spectrum, the overall industry is segmented into ambulatory surgical centres, and hospitals. The market share from ambulatory surgical centres was valued at USD 92 million in 2019 and is slated grow significantly over the forecast years.
Considering the regional landscape, Latin America left atrial appendage closure devices market was remunerated at USD 9.1 million in 2019 and is reckoned to grow with a CAGR of 24% through 2026. Meanwhile, Middle East & Africa industry amassed USD 7.5 million in 2019 and is predicted to record a y-o-y growth rate of 23% over the analysis timeframe, claims the report.
Speaking of competitive terrain, worldwide left atrial appendage closure devices market dynamics are defined by companies such as Occlutech GmbH, LifeTech Scientific Corp., Johnson & Johnson, Boston Scientific Corp., ArtiCure, and Abbott Laboratories.